Search Results - David R Newell

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice. by Emma J Haagensen, Huw D Thomas, Ian Wilson, Suzannah J Harnor, Sara L Payne, Tommy Rennison, Kate M Smith, Ross J Maxwell, David R Newell

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  2. 2

    Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM by Elizabeth C. Matheson, Huw Thomas, Marian Case, Helen Blair, Rosanna K. Jackson, Dino Masic, Gareth Veal, Chris Halsey, David R. Newell, Josef Vormoor, Julie A.E. Irving

    Published in Haematologica (2019-09-01)
    Get full text
    Article


  3. 3

    Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer. by Kelly Coffey, Timothy J Blackburn, Susan Cook, Bernard T Golding, Roger J Griffin, Ian R Hardcastle, Lorraine Hewitt, Kety Huberman, Hesta V McNeill, David R Newell, Celine Roche, Claudia A Ryan-Munden, Anna Watson, Craig N Robson

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


Search Tools: